- Home
- DPRO vs FGEN Comparison
DPRO vs FGEN Comparison
Compare DPRO & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DPRO
- FGEN
- Stock Information
- Founded
- DPRO 1998
- FGEN 1993
- Country
- DPRO Canada
- FGEN United States
- Employees
- DPRO N/A
- FGEN N/A
- Industry
- DPRO Aerospace
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- DPRO Industrials
- FGEN Health Care
- Exchange
- DPRO Nasdaq
- FGEN Nasdaq
- Market Cap
- DPRO 38.9M
- FGEN 33.5M
- IPO Year
- DPRO N/A
- FGEN 2014
- Fundamental
- Price
- DPRO $5.59
- FGEN $7.80
- Analyst Decision
- DPRO Strong Buy
- FGEN Strong Buy
- Analyst Count
- DPRO 2
- FGEN 1
- Target Price
- DPRO $6.50
- FGEN $250.00
- AVG Volume (30 Days)
- DPRO 5.7M
- FGEN 61.0K
- Earning Date
- DPRO 08-12-2025
- FGEN 08-05-2025
- Dividend Yield
- DPRO N/A
- FGEN N/A
- EPS Growth
- DPRO N/A
- FGEN N/A
- EPS
- DPRO N/A
- FGEN N/A
- Revenue
- DPRO $4,716,450.00
- FGEN $6,996,000.00
- Revenue This Year
- DPRO $94.01
- FGEN N/A
- Revenue Next Year
- DPRO $95.14
- FGEN N/A
- P/E Ratio
- DPRO N/A
- FGEN N/A
- Revenue Growth
- DPRO 7.90
- FGEN N/A
- 52 Week Low
- DPRO $1.55
- FGEN $4.50
- 52 Week High
- DPRO $7.31
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- DPRO 62.60
- FGEN 67.08
- Support Level
- DPRO $3.23
- FGEN $7.03
- Resistance Level
- DPRO $7.31
- FGEN $5.73
- Average True Range (ATR)
- DPRO 0.50
- FGEN 0.57
- MACD
- DPRO 0.27
- FGEN 0.35
- Stochastic Oscillator
- DPRO 54.78
- FGEN 100.00
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.